Journal of Bacteriology, June 1999, p. 3392-3401, Vol. 181, No. 11
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
andDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts 02111
Received 25 January 1999/Accepted 30 March 1999
| |
ABSTRACT |
|---|
|
|
|---|
Deletion of the citC gene, coding for isocitrate
dehydrogenase, arrests sporulation of Bacillus subtilis at
stage I after bipolar localization of the cell division protein FtsZ
but before formation of the asymmetric septum. A spontaneous extragenic
suppressor mutation that overcame the stage I block was found to map
within the spoVG gene. The suppressing mutation and other
spoVG loss-of-function mutations enabled citC
mutant cells to form asymmetric septa and to activate the
forespore-specific sigma factor
F. However, little
induction of mother cell-specific,
E-dependent
sporulation genes was observed in a citC spoVG double mutant, indicating that there is an additional defect(s) in
compartmentalized gene expression in the citC mutant. These
other defects could be partially overcome by reducing the synthesis of
citrate, by buffering the medium, or by adding excess
MnCl2. Overexpression of the spoVG gene in
wild-type cells significantly delayed
F activation.
Increased expression and stability of SpoVG in citC mutant
cells may contribute to the citC mutant phenotype.
Inactivation of the spoVG gene caused a population of
otherwise wild-type cells to produce a small number of minicells during
growth and caused sporulating cells to complete asymmetric septation
more rapidly than normal. Unlike the case for inactivation of the cell
division inhibitor gene minD, many of these minicells
contained DNA and appeared only when the primary sporulation signal
transduction pathway, the Spo0A phosphorelay, was active. These results
suggest that SpoVG interferes with or is a negative regulator of the
pathway leading to asymmetric septation.
| |
INTRODUCTION |
|---|
|
|
|---|
Spore formation in Bacillus subtilis is a developmental pathway in which sequential, compartmentalized gene expression is achieved by interlocking cascades of regulatory factors and morphological cues (67). The primary environmental signal for initiation of sporulation is nutrient limitation (63), but this same condition also induces other adaptive responses (e.g., genetic competence, degradative enzyme synthesis, chemotaxis and motility, and antibiotic production) characteristic of slowly growing or stationary-phase cells.
The earliest morphological change that distinguishes a sporulating from
a nonsporulating stationary-phase cell is the formation of an
asymmetrically disposed division septum (48). During
exponential growth, B. subtilis cells, like those of most
other rod-shaped bacteria, divide exclusively at mid-cell. Mid-cell
division requires the assembly at the septation site of a protein
complex that includes FtsZ (4, 6), a tubulin-like GTPase
(11, 50). Formation of a ring of FtsZ at the site of future
septation is a prerequisite for association of other proteins with this
site (25) and for septation itself. When a B. subtilis cell initiates sporulation, rings of FtsZ protein form at
the two poles of the cell rather than at mid-cell (36). One
of these rings becomes the site of asymmetric (polar) septation; the
other ring dissociates. Bipolar localization of FtsZ is thought to be
mediated by the product of a gene that depends on the Spo0A
transcription factor for its expression, since in a spo0A
mutant strain, polar rings of FtsZ do not form in stationary phase
(36). Another factor required for polar septation is thought
to be the product of a gene transcribed by the
H form of
RNA polymerase, since a spo0H (
H) mutant does
not form polar septa even though FtsZ rings assemble at polar sites
(36).
Asymmetric septation permits forespore-specific activation of
F (1, 16, 42), the first step in a cascade of
gene expression determined by sequentially active
factors
(67). Soon after
F becomes active, its
activity leads to signals that activate
E in the mother
cell (27, 32, 37), followed by activation of
G in the forespore (46, 68) and
K in the mother cell (9, 10, 39).
The nutritional signal that initiates sporulation is unknown but is assumed to be created intracellularly by normal metabolism (63). It has long been known that the enzymes of the Krebs citric acid cycle are induced as cells leave exponential growth phase; activities of the enzymes are required for successful sporulation (18, 21, 54, 72). To investigate the specific roles of Krebs cycle enzymes in spore formation, we have analyzed the stages of sporulation blockage in mutants deficient in various steps of the cycle (8, 29, 31). We found that the absence of the third enzyme, isocitrate dehydrogenase (ICDH), causes a specific block at stage I (31); mutant cells enter stationary phase, organize their chromosomes in an axial filament (as in wild-type cells), and assemble apparently normal rings of FtsZ protein at both poles (31). No polar septation occurs, however. In the accompanying paper (41), we show that abnormally high accumulation of citrate is responsible, at least in part, for this phenotype.
To understand the basis for this stage I block and to identify proteins
that may participate in or regulate asymmetric septation, we sought
suppressor mutations that would restore polar septation to an ICDH
(citC) mutant strain. To do so, we searched for spontaneous pseudorevertants of a citC null mutant in which expression
of the
F-dependent gene spoIIQ
(38) was restored. One such mutation proved to be in the
spoVG gene (53, 56, 58), whose product was not
previously known to affect the pathway leading to asymmetric septation.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Strains and growth conditions.
The B. subtilis
strains and plasmids used in this study are listed in Table
1. Cells were grown in nutrient broth
sporulation (DS) medium (19) supplemented with antibiotics
(5), if necessary. Sporulation was induced either by
nutrient exhaustion in DS broth or by a resuspension method
(65). LacZ indicator plates contained 5-bromo-4-chloro-3-indolyl-
-D-galactoside (X-Gal) at 80 µg/ml. Escherichia coli JM107 (71) was used for
construction of plasmids.
|
DNA manipulation and transformation. Plasmid DNA was isolated from E. coli cells by a modified version of the method of He et al. (26). Other DNA manipulations were done by standard protocols (55). Preparation of electroporation-competent cells of E. coli and transformation with a Bio-Rad GenePulser apparatus (Bio-Rad Laboratories) were performed by the method of Dower et al. (14). Chromosomal DNA from B. subtilis was prepared as described previously (19). Transformation of B. subtilis cells with chromosomal DNA or plasmids was done by the procedure of Dubnau and Davidoff-Abelson (15).
Construction of an integrative genomic library of B. subtilis.
A B. subtilis integrative plasmid, pPS34, and
a B. subtilis genomic library were constructed by Pascale
Serror (59). pPS34 was created by ligating the 2.8-kb
SspI fragment of pBluescript SK(
) (pSK
) (Stratagene,
Inc.) to a 1.35-kb erythromycin resistance gene (erm)
excised from pJPM9 (43) as a blunt-ended
EcoRI-HindIII fragment. The erythromycin
cassette was inserted in the same orientation as the lacZ
gene of pSK
. For construction of a B. subtilis genomic library, chromosomal DNA from strain FJS107 (Table 1) was digested separately with AluI, HinpI, and
HpaII. After HinpI and HpaI fragments were blunt ended, they and the AluI fragments were inserted
in separate ligations in the EcoRV site of pPS34. The cloned
DNAs were pooled and, in a subsequent transformation, integrated into the chromosome of JH642 by homologous recombination. DNA from the
pooled Ermr transformants was prepared for use as a random
insertion library.
Transfer of a suppressor mutation.
Competent cells of strain
SJB219 (
citC::spc) (Table 1) were
transformed with the chromosomal DNA from a spontaneous
pseudorevertant, KMB77S3 (
citC::spc
amyE::[spoIIQ'-lacZ cat]
spoVG2), and chloramphenicol-resistant (Camr)
transformants were selected. Most were slightly blue on DS plates containing X-Gal, but some colonies were as dark blue as KMB77S3, indicating that the unlinked spoVG2 mutation and the
spoIIQ'-lacZ fusion were cotransferred by congression. One
of the congressants, KMB97, was used for subsequent mapping experiments
(see Results).
Cloning of the spoVG2 mutant allele.
The
spoVG locus of KMB97, located within a 680-bp
HindIII fragment, was amplified by PCR with the
following primers: 5'-AAGTGATTCTGGGAGAGCCGGGATC-3' (which
anneals about 170 bp upstream of the spoVG initiation codon) and 5'-AGGCTTACCGCAAACTGGATGAAGG-3' (which anneals about 280 bp downstream of the spoVG termination codon). The amplified
DNA fragment (770 bp) was cloned directly into the modified
EcoRV site of pT7Blue(R) (Novagen, Inc.). The resulting
plasmid (pKM73) was sequenced to confirm that there were no additional
mutations other than spoVG2 in the spoVG open
reading frame. In order to eliminate possible PCR-derived mutations in
the spoVG promoter, the BstXI-SacI
fragment containing the spoVG2 mutation was excised and
fused to the 5' end of wild-type spoVG in pKM70 which had been digested with the same enzymes, creating pKM89. To create pKM70,
the spoVG-containing 680-bp HindIII fragment
from pLS5 (a pBR322 derivative) (64) was inserted at the
HindIII site of a version of pSK
with a disrupted
BstXI site in its multicloning site.
Overexpression of spoVG and preparation of anti-SpoVG antibodies. A strain producing a maltose-binding protein (MBP)-SpoVG fusion protein was constructed as follows. A BamHI site was introduced by PCR just upstream of the initiation codon of spoVG, and the amplified fragment was cloned in pT7Blue(R). A 300-bp BamHI fragment from the resulting plasmid was inserted in the proper orientation at the BamHI site of pMAL-c2 (New England Biolabs), a plasmid for construction of MBP fusions, to create pKM102. E. coli JM107 harboring pKM102 was used for overexpression of MBP-SpoVG.
Cells were grown to mid-exponential phase (optical density at 600 nm of 0.5) in 500 ml of L broth supplemented with 0.2% glucose and 100 µg of ampicillin per ml; 1 mM isopropyl-thio-
-D-galactosidase (IPTG) was added to the
culture, and incubation was continued for 2.5 h. Cells were
harvested, washed once with column buffer (20 mM Tris-HCl buffer [pH
7.4] containing 200 mM NaCl, 1 mM EDTA, 10 mM
-mercaptoethanol, and
0.5 mM phenylmethylsulfonyl fluoride [PMSF]), and resuspended in 10 ml of the same buffer. Cells were disrupted by sonication and
centrifuged to remove cell debris. Supernatant fluid was applied to an
amylose column (
5 ml) that had been equilibrated with column buffer.
After extensive washing of the column, MBP-SpoVG was eluted with column
buffer containing 10 mM maltose. Fractions containing MBP-SpoVG were
collected and dialyzed against 20 mM Tris-HCl buffer (pH 8) containing
100 mM NaCl and 2 mM CaCl2. About 30 µg of factor Xa
(Boehringer Mannheim) was incubated overnight at 4°C with 9 mg of
MBP-SpoVG. The reaction mixture was dialyzed against 20 mM Tris-HCl
buffer (pH 8) containing 25 mM NaCl and 0.5 mM PMSF and then
centrifuged. The supernatant fluid was subjected to DEAE-Sephacel
chromatography to remove factor Xa. SpoVG and MBP-SpoVG coeluted
from the DEAE column in a gradient of NaCl (25 to 500 mM). Fractions
containing SpoVG and MBP-SpoVG were pooled and subsequently applied to
an amylose column to separate SpoVG from residual MBP-SpoVG fusion
protein. The flowthrough fraction from each preparation typically
contained about 0.75 mg of SpoVG polypeptide.
SpoVG polypeptide (1 mg) was mixed with adjuvant and injected into a
female New Zealand White rabbit. Injections and bleedings were done
with the assistance of Sada Yaser, Tufts University Animal Care
Facility. To remove nonspecific antibodies, the antisera against SpoVG
were mixed with a crude extract of a spoVG null mutant and
kept on ice for 1 h. After centrifugation, antibodies in the
supernatant fluid were partially purified by differential ammonium
sulfate precipitation (35 to 50% of saturation).
Immunoblot analysis. Cells were harvested from a 50-ml culture in DS medium, washed once with 50 mM HEPES buffer (pH 8) containing 1 mM EDTA, 150 mM NaCl, 5 mM MgCl2, 10% glycerol, and 0.5 mM PMSF, and resuspended in 2 ml of the same buffer. Cells were disrupted by sonication followed by centrifugation to remove cell debris. Supernatant fluid (crude extract; 10 µg protein) was subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and then electrotransferred to an Immobilon-P (Millipore Corp.) membrane. The membrane was exposed to anti-SpoVG antibodies, and the immune complexes were visualized by using color-forming substrates of an alkaline phosphatase-linked secondary antibody (30).
Microscopic analysis. Fixation of cells and DNA staining with 4,6-diamidino-2-phenylindole (DAPI) were done essentially by the method of Wu et al. (70). Cells were harvested before and after induction of sporulation by the resuspension method (65) and fixed in 70% ethanol. Cell suspensions were kept at 4°C overnight, and subsequently subjected to nucleoid staining (1 µg of DAPI per ml). Samples were observed by using an Olympus BX60 microscope equipped with a C4742-95 digital camera (Hamamatsu). Images were processed with Image Pro Plus version 3.0 (Media Cybernetics) and Adobe Photoshop.
Samples for thin-section electron microscopic analysis were prepared as described previously (31) and visualized by A. Brown-Cormier, Electron Microscopy Unit, Department of Anatomy and Cellular Biology, Tufts University.Construction of other plasmids. pKM56 was constructed by inserting the 680-bp HindIII fragment of pLS5 (see above) in the HindIII site of pDG1664, a B. subtilis integration vector for the thrC locus (22).
Plasmid pKM82, a derivative of pSK
, contains the spoVG
gene within a HindIII fragment excised from pLS5 (see
above). The orientation of the spoVG gene in pKM82 is such
that transcription is in the direction opposite that of
lacZ. pKM98 was constructed by ligating a
PstI-SalI fragment of pKM82 to pHP13
(23), which had been digested with the same enzymes. The
spoVG2 allele was removed from pKM89 as a
BamHI-SalI fragment and inserted at the corresponding sites of pHP13, creating pKM157.
Other methods.
DNA sequencing was done by using a Sequenase
reagent kit (U.S. Biochemical Corp.) or by M. Berne, Tufts University
Protein and Nucleic Acid Analysis Facility, using an ABI Automated
Sequencer. Direct sequencing of PCR-amplified fragments was performed
after treatment of the fragments with shrimp alkaline phosphatase and exonuclease I (U.S. Biochemical Corp.) according to the manufacturer's instructions. DNA sequences were analyzed with the DNA Strider and
BLAST programs (2).
-Galactosidase activity was measured and expressed as Miller units as described previously (61). All oligonucleotides used in this study were synthesized by M. Berne.
| |
RESULTS |
|---|
|
|
|---|
Isolation of spontaneous suppressor mutations that restore
expression of spoIIQ-lacZ in a
citC
mutant.
Sporulation of an ICDH
(
citC::spc) null mutant is blocked
at stage I after expression of Spo0A-phosphate-dependent genes and
bipolar localization of FtsZ rings early in stationary phase but before
the formation of an asymmetric septum at one of the cell poles
(31). Because of the failure of asymmetric septum formation,
neither forespore-specific,
F-dependent genes nor mother
cell-specific,
E-dependent genes are turned on in the
citC mutant (31). To investigate the basis of
the stage I block, extragenic suppressor mutations were sought by
looking for spontaneous variants of the
citC mutant in
which expression of
F-dependent genes was restored. For
this purpose, we used a
citC mutant strain (SJB295)
carrying a fusion of the E. coli lacZ gene to the
F-dependent promoter of the spoIIQ gene
(38). In independent trials, two spontaneous mutants were
isolated as dark blue colonies on plates of DS medium containing X-Gal.
These colonies were as translucent as those of the
citC
mutant, indicating that they were still defective in sporulation. In
transformation crosses, the suppressing mutations proved to be unlinked
to citC or to the spoIIQ'-lacZ fusion integrated
at the amyE locus. The spoIIQ'-lacZ fusion and
the suppressing mutation of one of the strains were simultaneously moved by congression into strain SJB219
(
citC::spc), creating strain
KMB97 (see Materials and Methods). As shown in Fig.
1a, spoIIQ'-lacZ expression in
strain KMB97 was increased in stationary phase to almost 50% of that
of the wild-type strain.
|
Identification of the spoVG2 mutation. To map the suppressing mutation in KMB97, we initially transformed strain KMB97 with a chromosomal library of random integrations of pPS34 (Ermr; see Materials and Methods). DNA from the pooled transformants was then used to transform strain SJB295. Ermr transformants that formed blue colonies on plates of DS medium containing X-Gal were tested individually for linkage of the suppressing mutation to erm. The location of an integrated plasmid showing about 50% linkage to the suppressing mutation was determined by cleavage of chromosomal DNA with EcoRI, ligation at a low DNA concentration, transformation of E. coli, extraction of plasmid, and sequencing of the cloned insert. The site of plasmid insertion was in the 5' end of the mfd gene (44), located at 7° on the chromosomal map. Further genetic crosses demonstrated that the mutation is 30% linked to abrB (47), located about 15 kb upstream of the mfd gene, and 70% linked to each of two insertion mutations previously shown to flank the spoVG gene (24). The spoVG locus of KMB97 was amplified by PCR and direct sequence analysis of the PCR-amplified fragments showed a point mutation (CCT to CTT), causing a single amino acid substitution from proline to leucine at residue 63. This mutation was designated spoVG2. Subsequently, the spoVG2 mutant allele was cloned and the presence of the mutation was confirmed by sequence analysis. The second, independently isolated, suppressor mutant was found to have the same mutation, perhaps because this mutation causes the same phenotype as a null mutation (see below).
Proof that spoVG2 is the suppressing mutation and is
recessive.
When the wild-type spoVG gene was introduced
at the thrC locus in KMB97, the suppressor mutant phenotype
disappeared (Fig. 2), indicating that
spoVG2 is required for suppression and that the
spoVG2 mutation is recessive to the wild-type
spoVG+. The recessiveness of spoVG2
suggests that it is a loss-of-function mutation. To confirm this point,
we tested the ability of null alleles of spoVG to suppress
the
citC mutation. When
spoVG::Tn917
HU265 (56) or
spoVG::tet (66) was
introduced into the
citC mutant (creating strain KMB136
or KMB198, respectively), the expression of the spoIIQ gene
in each of the citC spoVG mutants was indistinguishable from
that in KMB97 (Fig. 1a and data not shown), implying that the
spoVG2 mutation abolishes a negative effect of SpoVG on
F activation in the
citC mutant.
|
Expression of spoVG in a citC mutant.
Although
citC mutant cells were known to express the
spoVG gene and have no defect in
H activity
(31), we reexamined spoVG gene expression in
detail. As shown in Fig. 3a,
spoVG expression was induced at the normal time in the
mutant at the onset of sporulation but, unlike the case for the
wild-type strain, failed to shut off after T1 (1 h after the onset of stationary phase), reaching a maximum level approximately twofold higher than that seen in the wild-type strain.
|
citC
mutant, the level of SpoVG was constant throughout stationary phase,
remaining at nearly the maximal level seen in the wild-type strain
(Fig. 3b), raising the possibility that the phenotype of a
citC mutant is due, at least in part, to prolonged
expression or stability of SpoVG.
Overexpression of spoVG in B. subtilis.
To
assess further the potential negative effect of SpoVG on asymmetric
septation, we measured the effect on wild-type cells of overexpression
of spoVG. We used a low-copy-number plasmid, pHP13, for this
purpose, since it is known that high dosage of the
H-dependent spoVG promoter results in severe
inhibition of sporulation at an early stage (3, 73). Figure
4 shows that, in wild-type cells
harboring spoVG+ on pHP13 (pKM98),
F-dependent spoIIQ expression was
significantly delayed. This inhibitory effect was not caused by
titration by the spoVG promoter of any regulatory factor,
since no detectable difference in spoIIQ expression was
found in cells carrying the plasmid-borne spoVG2 allele
compared to cells carrying the vector only.
|
Sporulation gene expression in a citC spoVG double
mutant.
Since colonies of a
citC::spc
spoVG::tet double mutant were as
translucent as those of the original
citC mutant and the number of heat-resistant spores, measured at about
T20, was nearly identical to that of the
citC mutant (Table 2), we
examined later stages of the sporulation pathway to identify the
defect. The expression of the mother cell-specific,
E-dependent spoIID gene (52) is
normally induced following activation of
F in the
forespore. However, in the
citC
spoVG double mutant, there was relatively little induction of spoIID'-lacZ (Fig.
1b). As expected from the low level of
E activity in the
mother cell, there was little or no expression of the later sporulation
genes sspE (17) and cotA
(57), which are transcribed by RNA polymerases containing
G and
K, respectively (data not shown).
These defects were not due to the spoVG mutation, since a
spoVG single mutant had no detectable deficit in
spo gene expression (data not shown) and sporulated at close
to the wild-type frequency (reference 53 and Table 2).
|
citC
spoVG
mutant revealed that approximately 20% of the population of cells
formed the sporulation-specific asymmetric septum, i.e., overcame the stage I block in sporulation characteristic of the
citC
single mutant, and proceeded further in the developmental pathway (Fig. 5). At T6,
engulfment of the forespore (normally seen at T3 to T4) may have been completed in a few cells, but no further
development was seen. It seems that post-stage I defects remain
unsuppressed in the citC spoVG double mutant.
|
citC mutant can be partially overcome by a reduction in
citrate accumulation (41). To see whether the citrate and
spoVG effects are additive, we created a triple mutant
strain from which citZ (the major citrate synthase gene),
citC, and spoVG had been deleted. In this strain,
expression of spoIIQ'-lacZ was nearly as high as in
wild-type cells, and expression of both spoIID'-lacZ and sspE'-lacZ was increased (Table
3). The inhibitory effect of excess
citrate is due to a decrease in pH and chelation of divalent cations
(41). Thus, the effect of the citZ mutation on a
citC spoVG double mutant could be mimicked by supplementing
the medium with HEPES buffer (pH 8) or excess MnCl2 (Table
3). Simultaneous addition of HEPES and excess Mn2+ to
citC spoVG double-mutant cells allowed significant
restoration of expression of all spo genes tested (Table 3),
yet the cells still did not form heat-resistant spores efficiently
(7.2 × 106 per ml). This result presumably indicates
that the absence of ICDH activity causes additional physiological
changes that we have yet to identify.
|
Minicell formation in spoVG null mutant. Since the phenotype of the spoVG mutant suggests that the wild-type protein interferes with asymmetric septation, we tested the effects on cell division and sporulation of a spoVG mutation alone or in combination with a mutation in minD, a gene whose product inhibits polar septation during exponential growth (34, 35, 69). We confirmed that single null mutations in either spoVG or minD had relatively small effects on sporulation frequency (34, 35, 53). In our hands, the numbers of viable cells and spores obtained with either strain were decreased to about 50% of those of the wild-type strain after growth overnight in DS broth (Table 2 and data not shown). The minD spoVG double mutant suffered further losses in viability and spore titer to 30 and 10%, respectively (data not shown). The impaired ability of the double mutant to maintain viability and produce spores was reflected in the production of minicells by single and double mutants. O. Resnekov (51) had noted previously that a spoVG null mutant produces minicells. We estimated the minicell fraction at 2 to 3% of total spoVG mutant cells during vegetative growth (Fig. 6 and Table 4). A minD mutant produced about 13% minicells.
|
|
spoVG mutant in more detail by visualization of septa
and nucleoids. Surprisingly, in addition to typical anucleate minicells, the
spoVG mutant culture also included cells
having unusual distributions of nucleoids, such as minicells containing a condensed nucleoid or cells with a disporic phenotype
(60), both occurring at a very low but significantly higher
frequency than in the wild-type strain (Fig. 6 and Table 4). When
mid-exponential-phase cells of the spoVG mutant were induced
to sporulate by the resuspension method to synchronize the initiation
of sporulation, significant numbers of anucleate minicells, minicells
containing nucleoids, and disporic cells were found in the
mutant culture at T1, and stage II cells
appeared earlier in the mutant culture than in the wild-type strain
culture (Fig. 6 and Table 4).
Since polar septation concomitant with condensation of the nucleoid in
the forespore compartment is the cell division event unique to
initiation of sporulation in B. subtilis, we tested the
contribution of the Spo0A phosphorelay (7), the essential signal transduction system for initiation of sporulation, to the formation of these kinds of minicells. When spo0F and
spo0B mutations were introduced into the
spoVG
mutant, few minicells of any type were observed in a vegetative cell
culture of the triple mutant. Similarly, a spo0A deletion
greatly decreased the frequency of minicells in the
spoVG
mutant culture (<0.13%). In contrast, formation of anucleate
minicells by a minD mutant was not affected by a
spo0A mutation.
To see whether the effects of a citC mutation would be
suppressed by a minD mutation, we tested
spoIIQ'-lacZ expression and sporulation in a citC
minD double mutant. A minD mutation had no effect on
sporulation frequency or expression of spoIIQ in a
citC mutant (data not shown).
| |
DISCUSSION |
|---|
|
|
|---|
Null mutations in the spoVG gene partially
relieve the stage I block of a
citC mutant, allowing a
significant fraction of the
citC mutant cell population
to form an asymmetric septum and activate expression of
F-dependent genes in the forespore compartment. This
evidence suggests that a normal function of ICDH overcomes the activity
of SpoVG, which is itself an inhibitor or a negative regulator of the
H-dependent pathway to the asymmetric septum. In other
work, we have shown that it is the enzymatic activity of ICDH that is
critical for completing stage I (31, 41).
spoVG was the first developmentally regulated gene cloned from B. subtilis (58). Close homologs are now known to exist in Bacillus megaterium, Clostridium acetobutylicum, Borrelia burgdorferi, and Archaeoglobus fulgidus, organisms which collectively represent gram-positive and -negative eubacteria and the archaea. Proline-63, the residue mutated in our suppressor strains, is conserved in all five SpoVG proteins.
The absence of SpoVG in sporulating cells of B. subtilis is
known to cause aberrations in the germ cell wall and the cortex, defects seen at T5 to T6
(stage V) (53), and to make the stage II defect of a
spoIIB mutant more severe (40). However,
extensive gene expression studies have shown that the spoVG
gene is a very early stationary phase gene, expressed at a significant
level even during exponential growth phase and further induced at the end of exponential phase (45, 74). This transcription
depends on the
H form of RNA polymerase and is partially
repressed during early exponential phase by a global negative
regulator, AbrB (74). The concentration of SpoVG protein
reaches a maximum level at the onset of stationary phase and decreases
substantially after T2, indicating that SpoVG
most likely has its primary function early in stationary phase. In the
citC mutant, spoVG expression is induced at
the normal time but continues to increase even after several hours in
stationary phase. Moreover, the level of SpoVG protein remains high at
a time when it is greatly diminished in wild-type cells. Thus, the
dependence of asymmetric septation on ICDH activity might be attributed
to an effect on SpoVG synthesis or stability. Asymmetric septation,
however, is an early event in stationary phase; it is uncertain whether
prolonged expression of SpoVG (seen after T1) is
in fact responsible for the primary effect of the citC
mutation. On the other hand, overexpression of spoVG in
wild-type cells interferes with asymmetric septation.
The MinCD complex is a cell division inhibitor in exponential-phase cells of B. subtilis (34, 35, 69), as well as in E. coli (12, 13). Cells lacking these proteins form septa at potential division sites near cell poles and produce anucleate minicells during vegetative growth (13). The Min proteins appear to mask the polar cell division sites in normal growing cells, restricting FtsZ ring formation to medial sites (49). (Under some growth conditions, other proteins can carry out this function in B. subtilis [36a].) The masked sites, however, must become accessible to FtsZ when B. subtilis cells enter the spore formation program, implying that polar septation inhibitors (e.g., MinCD) lose activity in stationary phase. Our finding that deletion of the spoVG gene increases the rate and extent of asymmetric septation in both wild-type and citC mutant cells suggests that a normal role of SpoVG in early stationary phase is to temporarily prevent asymmetric septation after the Min proteins cease to function. Perhaps the subtle defects observed in late sporulating cells of a spoVG mutant (40, 53) are due to the loss of precise timing of asymmetric septum formation.
Although the primary function of SpoVG seems to be to regulate asymmetric septation in stationary-phase cells, the spoVG gene is also expressed, albeit at a lower level, in a population of exponential-phase cells. The fact that an exponential-phase culture of the spoVG mutant contains some minicells with condensed nucleoids and cells with a disporic phenotype is consistent with a heterogeneous population in which some cells initiate sporulation while others grow. This supposition is consistent with our finding that appearance of the aberrant cells is dependent on the Spo0A phosphorelay.
While inactivation of SpoVG partially overcomes the stage I block of a
citC mutant, the cells do not complete the sporulation process or even proceed beyond stage III. Moreover, only a
subpopulation (<30%) of the citC spoVG double mutant cells
form asymmetric septa and the level of
F-dependent gene
expression reaches only 30 to 50% of the level in wild-type cells.
Further suppression of the stage I block in a citC mutant
requires reducing citrate synthesis or raising the pH of the medium and
supplementation with MnCl2 to compensate for
overaccumulation of citrate (41).
The mechanism by which SpoVG regulates the extent and timing of asymmetric septation is unknown. SpoVG may interact directly with the septation apparatus or may act indirectly by regulating the synthesis or stability of proteins required for septation. Future experiments will be directed toward identifying the mechanism by which SpoVG regulates asymmetric septation and the means by which ICDH activity intervenes in this process. A working model has the following elements. As cells make the transition from exponential growth to stationary phase, citC and spoVG are simultaneously induced. At the same time, polar sites for assembly of FtsZ-containing cell division complexes become unmasked, but polar septation is still prevented in an unknown way by newly accumulated SpoVG. As Krebs cycle enzymes, including ICDH, begin to function, acidic metabolites of the glycolytic pathway are assimilated, raising extracellular pH, inactivating SpoVG, and inducing asymmetric septation, a process that requires one or more Mn2+-dependent proteins. Our data, however, do not rule out the possibility that low pH, Mn2+ limitation, and SpoVG affect polar septation by independent mechanisms.
| |
ACKNOWLEDGMENTS |
|---|
We thank O. Resnekov, R. Losick, P. Levin, A. Grossman, and P. Stragier for providing strains, for helpful discussions, and for
sharing unpublished results; B. Belitsky, P. Fawcett, A. Grossman, R. Losick, N. King, and D. RayChaudhuri for helpful criticism of the
manuscript; S. Jin for providing strains; A. Serio for constructing
strains and assaying
-galactosidase activity; P. Serror for
constructing pPS28, pPS34, and genomic libraries; A. Brown-Cormier for
assistance with electron microscopy; and S. Yaser for preparation of
anti-SpoVG antisera.
This work was supported in part by a research grant (GM42219) from the U.S. Public Health Service to A.L.S.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Molecular Biology and Microbiology, Tufts University School of Medicine, 136 Harrison Ave., Boston, MA 02111-1800. Phone: (617) 636-6761. Fax: (617) 636-0337. E-mail: asonensh{at}opal.tufts.edu.
Present address: Department of Biotechnology, School of
Engineering, Osaka University, 2-1 Yamadaoka, Suita, Osaka, Japan.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Alper, S., L. Duncan, and R. Losick. 1994. An adenosine nucleotide switch controlling the activity of a cell type-specific transcription factor in B. subtilis. Cell 77:195-205[Medline]. |
| 2. | Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410[Medline]. |
| 3. | Banner, C. D., C. P. Moran, Jr., and R. Losick. 1983. Deletion analysis of a complex promoter for a developmentally regulated gene from Bacillus subtilis. J. Mol. Biol. 168:351-365[Medline]. |
| 4. |
Beall, B., and J. Lutkenhaus.
1991.
FtsZ in Bacillus subtilis is required for vegetative septation and for asymmetric septation during sporulation.
Genes Dev.
5:447-455 |
| 5. |
Belitsky, B. R.,
M. C. U. Gustafsson,
A. L. Sonenshein, and C. V. Wachenfeldt.
1997.
An lrp-like gene of Bacillus subtilis involved in branched-chain amino acid transport.
J. Bacteriol.
179:5448-5457 |
| 6. | Bi, E., and J. Lutkenhaus. 1991. FtsZ ring structure associated with division in Escherichia coli. Nature (London) 354:161-164[Medline]. |
| 7. | Burbulys, D., K. A. Trach, and J. A. Hoch. 1991. Initiation of sporulation in B. subtilis is controlled by a multicomponent phosphorelay. Cell 64:545-552[Medline]. |
| 8. |
Craig, J. E.,
M. J. Ford,
D. C. Blaydon, and A. L. Sonenshein.
1997.
A null mutation in the Bacillus subtilis aconitase gene causes a block in Spo0A-phosphate-dependent gene expression.
J. Bacteriol.
179:7351-7359 |
| 9. |
Cutting, S.,
A. Driks,
R. Schmidt,
B. Kunkel, and R. Losick.
1991.
Forespore-specific transcription of a gene in the signal transduction pathway that governs pro- K processing in Bacillus subtilis.
Genes Dev.
5:456-466 |
| 10. | Cutting, S., S. Roels, and R. Losick. 1991. Sporulation operon spoIVF and the characterization of mutations that uncouple mother-cell from forespore gene expression in Bacillus subtilis. J. Mol. Biol. 221:1237-1256[Medline]. |
| 11. | de Boer, P., R. Crossley, and L. Rothfield. 1992. The essential bacterial cell-division protein FtsZ is a GTPase. Nature (London) 359:254-256[Medline]. |
| 12. |
de Boer, P. A. J.,
R. E. Crossley, and L. I. Rothfield.
1988.
Isolation and properties of minB, a complex genetic locus involved in correct placement of the division site in Escherichia coli.
J. Bacteriol.
170:2106-2112 |
| 13. | de Boer, P. A. J., R. E. Crossley, and L. I. Rothfield. 1989. A division inhibitor and a topological specificity factor coded for by the minicell locus determine proper placement of the division septum in E. coli. Cell 56:641-649[Medline]. |
| 14. |
Dower, W. J.,
J. F. Miller, and C. W. Ragsdale.
1988.
High efficiency transformation of E. coli by high voltage electroporation.
Nucleic Acids Res.
16:6127-6145 |
| 15. | Dubnau, D., and R. Davidoff-Abelson. 1971. Fate of transforming DNA following uptake by competent Bacillus subtilis. J. Mol. Biol. 56:209-221[Medline]. |
| 16. |
Duncan, L.,
S. Alper,
F. Arigoni,
R. Losick, and P. Stragier.
1995.
Activation of cell-specific transcription by a serine phosphatase at the site of asymmetric division.
Science
270:641-644 |
| 17. |
Fajardo-Cavazos, P.,
F. Tovar-Rojo, and P. Setlow.
1991.
Effect of promoter mutations and upstream deletions on the expression of genes coding for small, acid-soluble spore proteins of Bacillus subtilis.
J. Bacteriol.
173:2011-2016 |
| 18. |
Fortnagel, P., and E. Freese.
1968.
Analysis of sporulation mutants. II. Mutants blocked in the citric acid cycle.
J. Bacteriol.
95:1431-1438 |
| 19. |
Fouet, A., and A. L. Sonenshein.
1990.
A target for carbon source-dependent negative regulation of the citB promoter of Bacillus subtilis.
J. Bacteriol.
172:835-844 |
| 20. |
Frandsen, N., and P. Stragier.
1995.
Identification and characterization of the Bacillus subtilis spoIIP locus.
J. Bacteriol.
177:716-722 |
| 21. |
Freese, E. B., and C. L. Marks.
1973.
Developmental block in citric acid mutants of Bacillus subtilis.
J. Bacteriol.
116:1466-1468 |
| 22. | Guérout-Fleury, A.-M., N. Frandsen, and P. Stragier. 1996. Plasmids for ectopic integration in Bacillus subtilis. Gene 180:57-61[Medline]. |
| 23. | Haima, P., S. Bron, and G. Venema. 1987. The effect of restriction on shotgun cloning and plasmid stability in Bacillus subtilis Marburg. Mol. Gen. Genet. 209:335-342[Medline]. |
| 24. |
Haldenwang, W. G.,
C. D. B. Banner,
J. F. Ollington,
R. Losick,
J. A. Hoch,
M. B. O'Connor, and A. L. Sonenshein.
1980.
Mapping a cloned gene under sporulation control by insertion of a drug resistance marker into the Bacillus subtilis chromosome.
J. Bacteriol.
142:90-98 |
| 25. | Hale, C. A., and P. A. J. de Boer. 1997. Direct binding of FtsZ to ZipA, an essential component of the septal ring structure that mediates cell division in E. coli. Cell 88:175-185[Medline]. |
| 26. | He, M., M. A. Kaderdhai, I. Adcock, and B. M. Austen. 1991. An improved and rapid procedure for isolating RNA-free Escherichia coli plasmid DNA. Genet. Anal. Tech. Appl. 8:107-110[Medline]. |
| 27. | Hofmeister, A. E. M., A. Londoño-Vallejo, E. Harry, P. Stragier, and R. Losick. 1995. Extracellular signal protein triggering the proteolytic activation of a developmental transcription factor in B. subtilis. Cell 83:219-226[Medline]. |
| 28. |
Ireton, K.,
D. Z. Rudner,
K. J. Siranosian, and A. D. Grossman.
1993.
Integration of multiple developmental signals in Bacillus subtilis through the Spo0A transcription factor.
Genes Dev.
7:283-294 |
| 29. |
Ireton, K.,
S. Jin,
A. D. Grossman, and A. L. Sonenshein.
1995.
Krebs cycle function is required for activation of the Spo0A transcription factor in Bacillus subtilis.
Proc. Natl. Acad. Sci. USA
92:2845-2849 |
| 30. |
Jin, S., and A. L. Sonenshein.
1996.
Characterization of the major citrate synthase of Bacillus subtilis.
J. Bacteriol.
178:3658-3660 |
| 31. |
Jin, S.,
P. A. Levin,
K. Matsuno,
A. D. Grossman, and A. L. Sonenshein.
1997.
Deletion of the Bacillus subtilis isocitrate dehydrogenase gene causes a block at stage I of sporulation.
J. Bacteriol.
179:4725-4732 |
| 32. |
Karow, M. L.,
P. Glaser, and P. J. Piggot.
1995.
Identification of a gene, spoIIR, that links the activation of E to the transcriptional activity of F during sporulation in Bacillus subtilis.
Proc. Natl. Acad. Sci. USA
92:2012-2016 |
| 33. |
LeDeaux, J. R., and A. D. Grossman.
1995.
Isolation and characterization of kinC, a gene that encodes a sensor kinase homologous to the sporulation sensor kinases KinA and KinB in Bacillus subtilis.
J. Bacteriol.
177:166-175 |
| 34. | Lee, S., and C. W. Price. 1993. The minCD locus of Bacillus subtilis lacks the minE determinant that provides topological specificity to cell division. Mol. Microbiol. 7:601-610[Medline]. |
| 35. |
Levin, P. A.,
P. Margolis,
P. Setlow,
R. Losick, and D. Sun.
1992.
Identification of Bacillus subtilis genes for septum placement and shape determination.
J. Bacteriol.
174:6717-6728 |
| 36. |
Levin, P. A., and R. Losick.
1996.
Transcription factor Spo0A switches the localization of the cell division protein FtsZ from a medial to a bipolar pattern in Bacillus subtilis.
Genes Dev.
10:478-488 |
| 36a. |
Levin, P. A.,
J. J. Shim, and A. D. Grossman.
1998.
Effect of minCD on FtsZ ring position and polar septation in Bacillus subtilis.
J. Bacteriol.
180:6048-6051 |
| 37. |
Londoño-Vallejo, J.-A., and P. Stragier.
1995.
Cell-cell signaling pathway activating a developmental transcription factor in Bacillus subtilis.
Genes Dev.
9:503-508 |
| 38. | Londoño-Vallejo, J.-A., C. Fréhel, and P. Stragier. 1997. spoIIQ, a forespore-expressed gene required for engulfment in Bacillus subtilis. Mol. Microbiol. 24:29-39[Medline]. |
| 39. |
Lu, S.,
R. Halberg, and L. Kroos.
1990.
Processing of the mother-cell factor, K, may depend on events occurring in the forespore during Bacillus subtilis development.
Proc. Natl. Acad. Sci. USA
87:9722-9726 |
| 40. |
Margolis, P. S.,
A. Driks, and R. Losick.
1993.
Sporulation gene spoIIB from Bacillus subtilis.
J. Bacteriol.
175:528-540 |
| 41. |
Matsuno, K.,
T. Blais,
A. W. Serio,
T. Conway,
T. M. Henkin, and A. L. Sonenshein.
1999.
Metabolic imbalance and sporulation in an isocitrate dehydrogenase mutant of Bacillus subtilis.
J. Bacteriol.
181:3382-3391 |
| 42. |
Min, K.-T.,
C. M. Hilditch,
B. Diederich,
J. Errington, and M. D. Yudkin.
1993.
F, the first compartment-specific transcription factor of B. subtilis, is regulated by an anti- factor that is also a protein kinase.
Cell
74:735-742[Medline].
|
| 43. |
Mueller, J. P.,
G. Bukusoglu, and A. L. Sonenshein.
1992.
Transcriptional regulation of Bacillus subtilis glucose starvation-inducible genes: control of gsiA by the ComP-ComA signal transduction system.
J. Bacteriol.
174:4361-4373 |
| 44. |
Ogasawara, N.,
N. Nakai, and H. Yoshikawa.
1994.
Systematic sequencing of the 180 kilobase region of the Bacillus subtilis chromosome containing the replication origin.
DNA Res.
1:1-14 |
| 45. |
Ollington, J. F.,
W. G. Haldenwang,
T. V. Huynh, and R. Losick.
1981.
Developmentally regulated transcription in a cloned segment of the Bacillus subtilis chromosome.
J. Bacteriol.
147:432-442 |
| 46. |
Partridge, S. R.,
D. Foulger, and J. Errington.
1991.
The role of F in prespore-specific transcription in Bacillus subtilis.
Mol. Microbiol.
5:757-767[Medline].
|
| 47. | Perego, M., G. B. Spiegelman, and J. A. Hoch. 1988. Structure of the gene for the transition state regulator, abrB: regulator synthesis is controlled by the spo0A sporulation gene in Bacillus subtilis. Mol. Microbiol. 2:689-699[Medline]. |
| 48. |
Piggot, P. J., and J. G. Coote.
1976.
Genetic aspects of bacterial endospore formation.
Bacteriol. Rev.
40:908-962 |
| 49. | Raskin, D. M., and P. A. J. de Boer. 1997. The MinE ring: an FtsZ-independent cell structure required for selection of the correct division site in E. coli. Cell 91:685-694[Medline]. |
| 50. | RayChaudhuri, D., and J. T. Park. 1992. Escherichia coli cell-division gene ftsZ encodes a novel GTP-binding protein. Nature (London) 359:251-254[Medline]. |
| 51. | Resnekov, O. Personal communication. |
| 52. |
Rong, S.,
M. S. Rosenkrantz, and A. L. Sonenshein.
1986.
Transcriptional control of the Bacillus subtilis spoIID gene.
J. Bacteriol.
165:771-779 |
| 53. |
Rosenbluh, A.,
C. D. B. Banner,
R. Losick, and P. C. Fitz-James.
1981.
Identification of a new developmental locus in Bacillus subtilis by construction of a deletion mutation in a cloned gene under sporulation control.
J. Bacteriol.
148:341-351 |
| 54. |
Rutberg, B., and J. A. Hoch.
1970.
Citric acid cycle: gene-enzyme relationships in Bacillus subtilis.
J. Bacteriol.
104:826-833 |
| 55. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 56. |
Sandman, K.,
R. Losick, and P. Youngman.
1987.
Genetic analysis of Bacillus subtilis spo mutations generated by Tn917-mediated insertional mutagenesis.
Genetics
117:603-617 |
| 57. | Sandman, K., L. Kroos, S. Cutting, P. Youngman, and R. Losick. 1988. Identification of the promoter for a spore coat protein gene in Bacillus subtilis and studies on the regulation of its induction at a late stage of sporulation. J. Mol. Biol. 200:461-473[Medline]. |
| 58. | Segall, J., and R. Losick. 1977. Cloned Bacillus subtilis DNA containing a gene that is activated early during sporulation. Cell 11:751-761[Medline]. |
| 59. | Serror, P. Personal communication. |
| 60. |
Setlow, B.,
N. Magill,
P. Febbroriello,
L. Nakhimovsky,
D. E. Koppel, and P. Setlow.
1991.
Condensation of the forespore nucleoid early in sporulation of Bacillus species.
J. Bacteriol.
173:6270-6278 |
| 61. | Slack, F. J., J. P. Mueller, M. A. Strauch, C. Mathiopoulos, and A. L. Sonenshein. 1991. Transcriptional regulation of a Bacillus subtilis dipeptide transport operon. Mol. Microbiol. 5:1915-1925[Medline]. |
| 62. |
Slack, F. J.,
J. P. Mueller, and A. L. Sonenshein.
1993.
Mutations that relieve nutritional repression of the Bacillus subtilis dipeptide permease operon.
J. Bacteriol.
175:4605-4614 |
| 63. | Sonenshein, A. L. 1989. Metabolic regulation of sporulation and other stationary-phase phenomena, p. 109-130. In I. Smith, R. A. Slepecky, and P. Setlow (ed.), Regulation of procaryotic development. American Society for Microbiology, Washington, D.C. |
| 64. | Sonenshein, A. L. Unpublished data. |
| 65. | Sterlini, J. M., and J. Mandelstam. 1969. Commitment to sporulation in Bacillus subtilis and its relationship to development of actinomycin resistance. Biochem. J. 113:29-37[Medline]. |
| 66. | Stragier, P. Personal communication. |
| 67. | Stragier, P., and R. Losick. 1996. Molecular genetics of sporulation in Bacillus subtilis. Annu. Rev. Genet. 30:297-341[Medline]. |
| 68. |
Sun, D.,
R. M. Cabrera-Martinez, and P. Setlow.
1991.
Control of transcription of the Bacillus subtilis spoIIIG gene, which codes for the forespore-specific transcription factor G.
J. Bacteriol.
173:2977-2984 |
| 69. |
Varley, A. W., and G. C. Stewart.
1992.
The divIVB region of the Bacillus subtilis chromosome encodes homologues of Escherichia coli septum placement (MinCD) and cell shape (MreBCD) determinants.
J. Bacteriol.
174:6729-6742 |
| 70. |
Wu, L. J.,
P. J. Lewis,
R. Allmansberger,
P. M. Hauser, and J. Errington.
1995.
A conjugation-like mechanism for prespore chromosome partitioning during sporulation in Bacillus subtilis.
Genes Dev.
9:1316-1326 |
| 71. | Yanisch-Perron, C., J. Vieira, and J. Messing. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103-119[Medline]. |
| 72. |
Yousten, A. A., and R. S. Hanson.
1972.
Sporulation of tricarboxylic acid cycle mutants of Bacillus subtilis.
J. Bacteriol.
109:886-894 |
| 73. |
Zuber, P.,
J. M. Healy, and R. Losick.
1987.
Effects of plasmid propagation of a sporulation promoter on promoter utilization and sporulation in Bacillus subtilis.
J. Bacteriol.
169:461-469 |
| 74. | Zuber, P., M. Marahiel, and J. Robertson. 1988. Influence of abrB on the transcription of the sporulation-associated genes spoVG and spo0H in Bacillus subtilis, p. 123-127. In A. T. Ganesan, and J. A. Hoch (ed.), Genetics and biotechnology of bacilli, vol. 2. Academic Press, Inc., San Diego, Calif. |
This article has been cited by other articles: